Loading clinical trials...
Loading clinical trials...
Evaluation of the Efficacy of Sildenafil on Time to Healing in Patients With Scleroderma and Ischaemic Digital Ulcers: a Prospective, Longitudinal, Randomized, Comparative, Double-blind, 2-parallel-arm, Placebo-controlled Study
Digital ulcers (DUs) are an expression of the microangiopathy in patients with scleroderma (SSc). DUs lead to pain and impaired hand use. DUs remain a severe complication for many patients and effective therapy remains elusive. In the present study, the investigators propose to evaluate the efficacy of Sildenafil in DUs healing in a randomized double blind control study in SSc patients.
This is a multicenter, prospective, longitudinal, randomized, comparative, double-blind, 2-parallel-arm, placebo-controlled study aimed to evaluate the efficacy of sildenafil 20 mg TID study on time to healing of DUs in SSc patients with ischaemic DUs. Approximately 120 patients aged from 18 years and above will be allocated to receive either placebo or sildenafil 20mg TID during 90 days. All potential subjects will present with ischaemic digital ulcers complicating scleroderma. An eligible digital ulcer must be beyond the proximal interphalangeal joint, on finger surface (included periungual ulcers), of ischemic origin according to the physician, and not over subcutaneous calcifications or bone relief.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
University Hospital, Nice
Nice, Alpes-Maritimes, France
Hautepierre Hospital
Strasbourg, Bas-Rhin, France
Nord Hospital
Marseille, Bouches du Rhone, France
CHU de Caen
Caen, Calvados, France
CHU Dijon
Dijon, Côte d'Or, France
CHU Dupuytren / dermatology
Limoges, Haute Vienne, France
CHU Dupuytren / Médecine Interne
Limoges, Haute Vienne, France
CHU de Rennes
Rennes, Ile Et Vilaine, France
University Hospital, Tours
Tours, Indre-et-Loire, France
University Hospital, Grenoble
Grenoble, Isère, France
Start Date
November 1, 2010
Primary Completion Date
August 1, 2013
Completion Date
August 1, 2013
Last Updated
February 3, 2014
84
ACTUAL participants
Sildenafil
DRUG
placebo
DRUG
Lead Sponsor
University Hospital, Lille
NCT07090226
NCT07326033
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT03508375